sumatriptan has been researched along with Obesity in 3 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the pathogenesis of migraine is very complex and has not been thoughtfully elucidated, general consensus exists to date that this condition should be considered a primary neurovascular disorder with an important inflammatory component." | 2.50 | Adiponectin and migraine: systematic review of clinical evidence. ( Borghi, L; Lippi, G; Mattiuzzi, C; Meschi, T; Targher, G, 2014) |
| "Pretreatment with Sumatriptan did not modify the GH response to clonidine or pyridostigmine, as assessed by the peak GH response and the area under the curve." | 1.29 | Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion. ( Bento, A; Dieguez, C; Mota, A; Peñalva, A; Pombo, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lippi, G | 1 |
| Meschi, T | 1 |
| Mattiuzzi, C | 1 |
| Borghi, L | 1 |
| Targher, G | 1 |
| Mota, A | 1 |
| Bento, A | 1 |
| Peñalva, A | 1 |
| Pombo, M | 1 |
| Dieguez, C | 1 |
| Mathew, NT | 1 |
| Ravishankar, K | 1 |
| Sanin, LC | 1 |
1 review available for sumatriptan and Obesity
| Article | Year |
|---|---|
Adiponectin and migraine: systematic review of clinical evidence.
Topics: Adiponectin; Adult; Comorbidity; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Migrain | 2014 |
2 other studies available for sumatriptan and Obesity
| Article | Year |
|---|---|
Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Topics: Arginine; Child; Clonidine; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gr | 1995 |
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studie | 1996 |